Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Douglas M. Guimarães, Luciana O. Almeida, Manoela D. Martins, Kristy A. Warner, Alan R. S. Silva, Pablo A. Vargas, Fabio D. Nunes, Cristiane H. Squarize, Jacques E. Nör, Rogerio M. Castilho
Published Jun 7, 2016 · Vol. 7, No. 27 · pp. 42447-42460
Thomas Melchardt, Clemens Hufnagl, David M. Weinstock, Nadja Kopp, Daniel Neureiter, Wolfgang Tränkenschuh, Hubert Hackl, Lukas Weiss, Gabriel Rinnerthaler, Tanja N. Hartmann, Richard Greil, Oliver Weigert, Alexander Egle
Published Jun 6, 2016 · Vol. 7, No. 32 · pp. 51494-51502
Chenglin Wu, Noel FCC de Miranda, Longyun Chen, Agata M. Wasik, Larry Mansouri, Wojciech Jurczak, Krystyna Galazka, Monika Dlugosz-Danecka, Maciej Machaczka, Huilai Zhang, Roujun Peng, Ryan D. Morin, Richard Rosenquist, Birgitta Sander, Qiang Pan-Hammarström
Published May 20, 2016 · Vol. 7, No. 25 · pp. 38180-38190
